Scoping Inquiry into the CervicalCheck Screening Programme: final report

Department of Health (DoH); Scally, Gabriel

dc.contributor.author	Department of Health (DoH)
dc.contributor.author	Scally, Gabriel
dc.date.accessioned	2018-09-28T16:48:07Z
dc.date.available	2018-09-28T16:48:07Z
dc.date.issued	2018-09-12
dc.identifier.uri	http://hdl.handle.net/10147/623840
dc.description	In August 2018, as a result of probing by the Scoping Inquiry, information was provided which indicated that slides from Ireland had been distributed by CPL to other laboratories to carry out at least part of the screening process. As detailed in the report, the Scoping Inquiry is now aware that slides were dealt with by laboratories in San Antonio and Victoria (both Texas), Honolulu (Hawaii), and Orlando (Florida). This information has only come to my attention in recent weeks. It clearly needs further and detailed examination, along with some closely associated issues of procurement and accreditation. I am happy to provide you with a supplementary report on these matters in due course. But I want to be clear that CPL is not a current provider, and has not been since 2013, nor are any of the other laboratories to which they distributed slides. All of the laboratories visited by the Scoping Inquiry team are meeting the regulatory requirements current in their own country. There is abundant research evidence that screening sensitivity varies in different countries. As far as can be ascertained, all the laboratories have performance which is acceptable in their country. There are many dedicated and experienced staff working in the screening services, including in CervicalCheck. Their skills and expertise should not be lost. With significant system change, effective leadership, improved clinical and public health medicine engagement, plus new and powerful patient advocacy, there is no reason why CervicalCheck should not deliver an outstanding service for the women of Ireland.	en_US
dc.language.iso	en	en_US
dc.publisher	Department of Health (DoH)	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	CERVICAL CANCER	en_US
dc.subject	CERVICAL SCREENING	en_US
dc.subject	INQUIRY	en_US
dc.subject.other	SCOPING INQUIRY	en_US
dc.title	Scoping Inquiry into the CervicalCheck Screening Programme: final report	en_US
dc.type	Report	en_US
refterms.dateFOA	2018-09-28T16:48:07Z